Sex-specific effects of SNAP-25 genotype on verbal memory and Alzheimer's disease biomarkers in clinically normal older adults
- PMID: 36807763
- PMCID: PMC10435666
- DOI: 10.1002/alz.12989
Sex-specific effects of SNAP-25 genotype on verbal memory and Alzheimer's disease biomarkers in clinically normal older adults
Abstract
Introduction: We tested sex-dependent associations of variation in the SNAP-25 gene, which encodes a presynaptic protein involved in hippocampal plasticity and memory, on cognitive and Alzheimer's disease (AD) neuroimaging outcomes in clinically normal adults.
Methods: Participants were genotyped for SNAP-25 rs1051312 (T > C; SNAP-25 expression: C-allele > T/T). In a discovery cohort (N = 311), we tested the sex by SNAP-25 variant interaction on cognition, Aβ-PET positivity, and temporal lobe volumes. Cognitive models were replicated in an independent cohort (N = 82).
Results: In the discovery cohort, C-allele carriers exhibited better verbal memory and language, lower Aβ-PET positivity rates, and larger temporal volumes than T/T homozygotes among females, but not males. Larger temporal volumes related to better verbal memory only in C-carrier females. The female-specific C-allele verbal memory advantage was evidenced in the replication cohort.
Conclusions: In females, genetic variation in SNAP-25 is associated with resistance to amyloid plaque formation and may support verbal memory through fortification of temporal lobe architecture.
Highlights: The SNAP-25 rs1051312 (T > C) C-allele results in higher basal SNAP-25 expression. C-allele carriers had better verbal memory in clinically normal women, but not men. Female C-carriers had higher temporal lobe volumes, which predicted verbal memory. Female C-carriers also exhibited the lowest rates of amyloid-beta PET positivity. The SNAP-25 gene may influence female-specific resistance to Alzheimer's disease (AD).
Keywords: Alzheimer's disease; SNAP-25; amyloid-beta; cognition; genetics; neuroimaging; neuropsychology; sex differences; temporal lobe; verbal memory.
© 2023 the Alzheimer's Association.
Conflict of interest statement
CONFLICT OF INTEREST STATEMENT
G.D.R. receives research support from Avid Radiopharmaceuticals, GE Healthcare, Genentech, and Life Molecular Imaging. He has received consulting fees from Alector, Eli Lilly, Merck, Genentech, GE Healthcare, and Roche. He is an Associate Editor for
Figures



